INFLUENCE OF FIBRINOLYTIC THERAPY ON THE APPEARANCE OF COMPLICATIONS IN ACUTE PHASE OF MYOCARDIAL INFARCTION IN PATIENTS WITH CONCOMITANT DIABETES MELLITUS TYPE 2

Authors

  • Kravchun P. G. Kharkiv National Medical University, Department of internal medicine № 2, clinical immunology and allergology
  • Babadjan V. D. Kharkiv National Medical University, Department of internal medicine № 2, clinical immunology and allergology
  • Zaikina T. S. Kharkiv National Medical University, Department of internal medicine № 2, clinical immunology and allergology

DOI:

https://doi.org/10.21856/j-PEP.2015.3.05

Keywords:

acute myocardial infarction, diabetes mellitus type 2, fibrinolytic therapy, complicated course, short-term prognosis

Abstract

It was examined 15 patients with acute myocardial infarction and were divided on groups depending on the presence or absence of concomitant diabetes mellitus type 2 and selected tactics of treatment (fibrinolytic or standart antiplatelet therapy). It was estimated requency of the complications development in acute period of myocardial infarction. It was found that patients with concomitant diabetes mellitus the most frequently had complicated course of acute phase of myocardial infarction in comparison with patients without previous fibrinolytic therapy. Using of fibrinolytic therapy has leveled the negative influence of diabetes mellitus on short-term prognosis of these patients. It’s confirmed the necessity of its carrying out in patients with co morbid pathology.

References

Belenkova YuA, Tavlueva EV, Karetnikova VN, et al. Ros Kardiol Zhurn 2012; 5(97):17-24.

Petina MM, Gorakovskaya GN, Martyinov AI. Ros Kardiol Zhurn 2011; 2(88):32-36.

Shtin SR. The influence of endothelial dysfunction on the thrombogenic status in patients with ischemic heart disease, Moskva, 2013: 26 p.

Valuyeva SV. Ukr Kardiol Zhurn 2012; 6:22-26.

Kolchin YuN, Sivtsova MA. Ukr Med Almanakh 2012; 15(4):211-216.

Shumakov VO,Malinovska IE, Tereshkevych LP, et al. Ukr Kardiol Zhurn 2013; 1:33-36.

Sena CM, Pereira AM,Seica R. Mol Basis Dis 2013; 1832:2216-2231.

Giraldez Roberto R, Clare Robert M, Lopes Renato D, et al. Amer Heart J 2013; 165:918-925.

Ketete Muluemebet, Cherqaoui Rabia, Maqbool Abid R., et al. J Biomed Sci Engineer 2013; 6:593-597.

Mahaffey Kenneth W, Hafley Gail, Dickerson Sheila, et al. Amer Heart J 2013; 166:240-249.

Weisenthal Benjamin M, Chang Anna Marie, Walsh Kristy M., Collin Mark J., Shofer Frances S., Hollander Judd E. American Journal of Cardiology, 2010; 165. 218-225.

Downloads

Published

2021-08-17

How to Cite

Kravchun, P. G. ., Babadjan, V. D. ., & Zaikina, T. S. . (2021). INFLUENCE OF FIBRINOLYTIC THERAPY ON THE APPEARANCE OF COMPLICATIONS IN ACUTE PHASE OF MYOCARDIAL INFARCTION IN PATIENTS WITH CONCOMITANT DIABETES MELLITUS TYPE 2. Problems of Endocrine Pathology, 53(3), 38-44. https://doi.org/10.21856/j-PEP.2015.3.05

Issue

Section

CLINICAL ENDOCRINOLOGY